2026-07-28Bullish
+9.30%24 hours changeIncyte stock rose after reporting Q2 2026 earnings that beat expectations and raising its full-year top-line sales guidance.
read the report →← every name covered
S&P 500
INCY
Incyte Corporation
latest move
+9.30%
2026-07-28
1 session · 2026-07-28 · avg 9.30% · largest 9.30%
Incyte Corporation is a global biopharmaceutical company specializing in the discovery, development, and commercialization of small-molecule and targeted biological therapeutics.